Home/Filings/4/0001179110-21-006951
4//SEC Filing

MOTT DARCY G 4

Accession 0001179110-21-006951

CIK 0001428336other

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 6:06 PM ET

Size

15.5 KB

Accession

0001179110-21-006951

Insider Transaction Report

Form 4
Period: 2021-06-21
MOTT DARCY G
Executive VP and CFO
Transactions
  • Sale

    Common Stock

    2021-06-21$77.68/sh3,204$248,87279,052 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-06-2110,00050,000 total
    Exercise: $14.00Exp: 2024-07-30Common Stock (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2021-06-21$14.00/sh+10,000$140,00085,052 total
  • Sale

    Common Stock

    2021-06-21$76.62/sh2,796$214,22282,256 total
Holdings
  • Stock Option (right to buy)

    Exercise: $25.39Exp: 2025-03-26Common Stock (25,000 underlying)
    25,000
  • Stock Option (right to buy)

    Exercise: $61.72Exp: 2028-03-27Common Stock (14,228 underlying)
    14,228
  • Stock Option (right to buy)

    Exercise: $73.61Exp: 2029-03-26Common Stock (15,337 underlying)
    15,337
  • Stock Option (right to buy)

    Exercise: $41.28Exp: 2027-03-27Common Stock (19,897 underlying)
    19,897
Footnotes (6)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 11, 2020.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.19 to $77.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) and (3) of this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.19 to $78.01, inclusive.
  • [F4]The option is immediately exercisable.
  • [F5]The option is exercisable as to 10,671 shares. The remaining 3,557 options vest on March 27, 2022.
  • [F6]The option is exercisable as to 7,669 shares. The remaining options vest as to 3,834 shares on each of March 27, 2022 and 2023.

Issuer

HEALTHEQUITY, INC.

CIK 0001428336

Entity typeother

Related Parties

1
  • filerCIK 0001179972

Filing Metadata

Form type
4
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 6:06 PM ET
Size
15.5 KB